Accès libre

Development and optimization of a sublingual tablet formulation for physostigmine salicylate

À propos de cet article

Martindale, The Complete Drug Reference, 35th ed., Pharmaceutical Press, London 2007, p. 1723.Search in Google Scholar

M. N. Madhat, Buccal and Sublingual Administration of Physostigmine, U.S. Pat. 6,264,974, 24 Jul 2001.Search in Google Scholar

R. Whelpton and P. Hurst, Bioavailability of oral physostigmine, New Eng. J. Med. 313 (1985) 1293-1294.10.1056/NEJM198511143132016Search in Google Scholar

D. Harris and J. R. Robinson, Drug delivery via the mucous membranes of the oral cavity, J. Pharm. Sci. 81 (1992) 1-10; DOI: 10.1002/jps.2600810102.10.1002/jps.2600810102Search in Google Scholar

P. Mura, S. Furlanetto, M. Cirri, F. Maestrelli, A. M. Marras and S. Pinzauti, Optimization of glibenclamide tablet composition through the combined use of differential scanning calorimetry and D-optimal mixture experimental design, J. Pharm. Biomed. Anal. 37 (2005) 65-71.10.1016/j.jpba.2004.09.047Search in Google Scholar

R. C. Hwang and D. L. Kowalski, Design of experiments for formulation development, Pharm Tech Dec 1, 2005.Search in Google Scholar

Introduction to Experimental Design, in Pharmaceutical Experimental Design and Interpretation, 2nd ed., N. A. Armstrong (Ed.), Taylor & Francis, London 2006, pp. 1-8.10.1201/9781420021455.ch1Search in Google Scholar

X. Jin, Y. Zhang, L. Xiao and Z. Zhao, Optimization of extended zero-order release gliclazide tablets using D-optimal mixture design, J. Pharm. Soc. Japan 128 (2008) 1475-1483.10.1248/yakushi.128.1475Search in Google Scholar

Y. El-Malah, S. Nazzal and N. M. Khanfar, D-optimal mixture design: optimization of ternary matrix blends for controlled zero-order drug release from oral dosage forms, Drug Dev. Ind. Pharm. 32 (2006) 1207-1218; DOI: 10.1080/03639040600685167.10.1080/03639040600685167Search in Google Scholar

S. S. Patel, S. Ray and R. S. Thakur, Formulation and evaluation of floating drug delivery system containing clarithromycin for Helicobacter pylori, Acta Pol. Pharm. 63 (2006) 53-61.Search in Google Scholar

Y. Gonnissen, S. I. Gonçalves, J. P. Remon and C. Vervaet, Mixture design applied to optimize a directly compressible powder produced via cospray drying, Drug Dev. Ind. Pharm. 34 (2008) 248-257; DOI: 10.1080/03639040701542143.10.1080/03639040701542143Search in Google Scholar

T. Nahata and T. R. Saini, D-optimal designing and optimization of long acting microsphere-based injectable formulation of aripiprazole, Drug Dev. Ind. Pharm. 34 (2008) 668-675; DOI: 10.1080/03639040701836545.10.1080/03639040701836545Search in Google Scholar

A. Bodea and S. E. Leucuta, Optimization of hydrophilic matrix tablets using a D-optimal design, Int. J. Pharm. 153 (1997) 247-255; DOI: 10.1016/S0378-5173(97)00117-8.10.1016/S0378-5173(97)00117-8Search in Google Scholar

R. C. Rowe, P. J. Sheskey and P. J. Weller, Handbook of Pharmaceutical Excipients, 5th ed., Pharmaceutical Press and American Pharmaceutical Association, London 2006.Search in Google Scholar

United States Pharmacopeia 31, National Formulary 26, The United States Pharmacopeial Convention, Rockville 2008.Search in Google Scholar

S. J. Ugarkovic, Sublingual Oral Dosage Form, U.S. Pat. 6,572,891, 3 Jun 2003.Search in Google Scholar

G. Derringer and R. Suich, Simultaneous optimization of several response variables, J. Qual. Tech. 12 (1980) 214-219.10.1080/00224065.1980.11980968Search in Google Scholar

H. L. Fung, S. K. Yap and C. T. Rhodes, Development of a stable sublingual nitroglycerin tablet II: formulation and evaluation of tablets containing povidone, J. Pharm. Sci. 65 (1976) 558-560; DOI: 10.1002/jps.2600650419.10.1002/jps.2600650419Search in Google Scholar

C. P. Lim, S. S. Quek and K. K. Peh, Prediction of drug release profiles using an intelligent learning system: an experimental study in transdermal iontophoresis, J. Pharm. Biomed. Anal. 31 (2003) 159-168; DOI: 10.1016/S0731-7085(02)00573-3.10.1016/S0731-7085(02)00573-3Search in Google Scholar

J. Klancke, Dissolution testing of orally disintegrating tablets, Diss. Tech. 10 (2003) 6-8.10.14227/DT100203P6Search in Google Scholar

eISSN:
1846-9558
ISSN:
1330-0075
Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Pharmacy, other